Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Ophthalmology
Early Initial Clinical Experience With Intravitreal Aflibercept For Wet Age-Related Macular Degeneration, P. J. Ferrone, F. Anwar, J. Naysan, K. Chaudhary, D. Fastenberg, K. Graham, V. Deramo
Early Initial Clinical Experience With Intravitreal Aflibercept For Wet Age-Related Macular Degeneration, P. J. Ferrone, F. Anwar, J. Naysan, K. Chaudhary, D. Fastenberg, K. Graham, V. Deramo
Journal Articles
Background Age-related macular degeneration (AMD) is a degenerative process that leads to severe vision loss. Wet AMD is defined by choroidal neovascularisation, leading to the accumulation of subretinal fluid (SRF), macular oedema (ME), and pigment epithelium detachments (PED). Purpose To evaluate the initial clinical experience of conversion from bevacizumab or ranibizumab to aflibercept in wet AMD patients. Methods Records of 250 consecutive wet AMD patients were retrospectively reviewed. Of 250 patients, 29 were naive (with no previous treatment), and 221 were previously treated with bevacizumab (1/3) or ranibizumab (2/3). On average, converted patients received 14 injections every 6 weeks on …